Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s11596-006-0516-5.

Title:
CD4+CD25high regulatory cells in peripheral blood of NSCLC patients | Current Medical Science
Description:
The proportion and changes of CD4+CD25high regulatory T cells (Trs) in peripheral blood of non-small cell lung cancer (NSCLC) patients were analyzed and their clinical significance explored. The peripheral blood was collected from 61 patients with NSCLC and 15 healthy controls. By using monoclonal antibodies, the blood samples were evaluated with the flow cytometry for lymphocyte subsets (CD3+, CD4+ and CD8+) and CD4+CD25high Tr cells. The results showed that the proportion of CD4+CD25high Tr cells in NSCLC group was significantly higher than in control group [(4.36±2.07) % vs (2.04±1.03) %, P<0.01]. The proportion of CD4+CD25high Tr cells in late stage was higher than that in early stage [stages: + II (2.26±0.6) %; stage III (3.28±1.38) %; stage IV (6.06±4.08) %] (P<0.05). Kaplan-Meier survival analysis revealed that the prognosis of the patients who had higher proportion of CD4+CD25high Tr cells in peripheral blood was worse (P=0.0026). In conclusion, the relative increase in CD4+CD25high Tr cells in peripheral blood may be related to immunosuppression and tumor progression in patients with NSCLC. This finding suggests that CD4+CD25+high Tr cells in peripheral blood of NSCLC may be positive for prognosis analysis. The use of depletion of the CD4+CD25high Tr cell therapy to treat NSCLC patients may be an effective strategy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

cells, article, cell, cdcdhigh, regulatory, google, scholar, pubmed, peripheral, blood, patients, cas, cancer, nsclc, lung, privacy, cookies, content, journal, research, huazhong, science, nonsmall, tumor, access, cdcd, analysis, information, publish, search, university, technology, proportion, stage, immunol, exp, data, log, liu, yao, ding, clinical, subsets, higher, prognosis, related, therapy, immune, discover, sakaguchi,

Topics {✒️}

cd4+cd25+high tr cells month download article/chapter cd4+cd25high tr cells cd4+cd25high regulatory cells cd4+cd25+ immunoregulatory cells tumor-draining lymph nodes subsets cd4+cd25high regulatory peripheral regulatory cd4+cd25hicd127low stem cell center full article pdf cd4+cd25high regulatory privacy choices/manage cookies immune cell populations cd4+cd25+ regulatory related subjects cd4+cd25+ suppressor anti-pd-1 therapy european economic area hla-dr expression interleukin-12 gene transfer tongji medical college distinguished young scholars conditions privacy policy tumor infiltrating lymphocytes article liu cd4+/cd8+ ratio human tumor immunology early stage [stages accepting optional cookies cancer immunol immunother article journal flow cytometry national science fundation clinical significance explored journal finder publish main content log human peripheral blood check access instant access article log cells regulatory cd4+cd25+ clinical research nsclc patients published treat nsclc patients article cite colorectal cancer cell subpopulation cell activation dendritic cell

Schema {🗺️}

WebPage:
      mainEntity:
         headline:CD4+CD25high regulatory cells in peripheral blood of NSCLC patients
         description:The proportion and changes of CD4+CD25high regulatory T cells (Trs) in peripheral blood of non-small cell lung cancer (NSCLC) patients were analyzed and their clinical significance explored. The peripheral blood was collected from 61 patients with NSCLC and 15 healthy controls. By using monoclonal antibodies, the blood samples were evaluated with the flow cytometry for lymphocyte subsets (CD3+, CD4+ and CD8+) and CD4+CD25high Tr cells. The results showed that the proportion of CD4+CD25high Tr cells in NSCLC group was significantly higher than in control group [(4.36±2.07) % vs (2.04±1.03) %, P<0.01]. The proportion of CD4+CD25high Tr cells in late stage was higher than that in early stage [stages: + II (2.26±0.6) %; stage III (3.28±1.38) %; stage IV (6.06±4.08) %] (P<0.05). Kaplan-Meier survival analysis revealed that the prognosis of the patients who had higher proportion of CD4+CD25high Tr cells in peripheral blood was worse (P=0.0026). In conclusion, the relative increase in CD4+CD25high Tr cells in peripheral blood may be related to immunosuppression and tumor progression in patients with NSCLC. This finding suggests that CD4+CD25+high Tr cells in peripheral blood of NSCLC may be positive for prognosis analysis. The use of depletion of the CD4+CD25high Tr cell therapy to treat NSCLC patients may be an effective strategy.
         datePublished:
         dateModified:
         pageStart:548
         pageEnd:551
         sameAs:https://doi.org/10.1007/s11596-006-0516-5
         keywords:
            non-small cell lung cancer
            T subsets
            CD4+CD25high regulatory T cell
            flow cytometry
            survival analysis
            Medicine/Public Health
            general
         image:
         isPartOf:
            name:Journal of Huazhong University of Science and Technology
            issn:
               1672-0733
            volumeNumber:26
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Huazhong University of Science and Technology
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Li Liu
               affiliation:
                     name:Huazhong University of Science and Technology
                     address:
                        name:Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Junxia Yao
               affiliation:
                     name:Huazhong University of Science and Technology
                     address:
                        name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qian Ding
               affiliation:
                     name:Huazhong University of Science and Technology
                     address:
                        name:Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shiang Huang
               affiliation:
                     name:Huazhong University of Science and Technology
                     address:
                        name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:CD4+CD25high regulatory cells in peripheral blood of NSCLC patients
      description:The proportion and changes of CD4+CD25high regulatory T cells (Trs) in peripheral blood of non-small cell lung cancer (NSCLC) patients were analyzed and their clinical significance explored. The peripheral blood was collected from 61 patients with NSCLC and 15 healthy controls. By using monoclonal antibodies, the blood samples were evaluated with the flow cytometry for lymphocyte subsets (CD3+, CD4+ and CD8+) and CD4+CD25high Tr cells. The results showed that the proportion of CD4+CD25high Tr cells in NSCLC group was significantly higher than in control group [(4.36±2.07) % vs (2.04±1.03) %, P<0.01]. The proportion of CD4+CD25high Tr cells in late stage was higher than that in early stage [stages: + II (2.26±0.6) %; stage III (3.28±1.38) %; stage IV (6.06±4.08) %] (P<0.05). Kaplan-Meier survival analysis revealed that the prognosis of the patients who had higher proportion of CD4+CD25high Tr cells in peripheral blood was worse (P=0.0026). In conclusion, the relative increase in CD4+CD25high Tr cells in peripheral blood may be related to immunosuppression and tumor progression in patients with NSCLC. This finding suggests that CD4+CD25+high Tr cells in peripheral blood of NSCLC may be positive for prognosis analysis. The use of depletion of the CD4+CD25high Tr cell therapy to treat NSCLC patients may be an effective strategy.
      datePublished:
      dateModified:
      pageStart:548
      pageEnd:551
      sameAs:https://doi.org/10.1007/s11596-006-0516-5
      keywords:
         non-small cell lung cancer
         T subsets
         CD4+CD25high regulatory T cell
         flow cytometry
         survival analysis
         Medicine/Public Health
         general
      image:
      isPartOf:
         name:Journal of Huazhong University of Science and Technology
         issn:
            1672-0733
         volumeNumber:26
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Huazhong University of Science and Technology
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Li Liu
            affiliation:
                  name:Huazhong University of Science and Technology
                  address:
                     name:Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Junxia Yao
            affiliation:
                  name:Huazhong University of Science and Technology
                  address:
                     name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qian Ding
            affiliation:
                  name:Huazhong University of Science and Technology
                  address:
                     name:Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shiang Huang
            affiliation:
                  name:Huazhong University of Science and Technology
                  address:
                     name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Huazhong University of Science and Technology
      issn:
         1672-0733
      volumeNumber:26
Organization:
      name:Huazhong University of Science and Technology
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Huazhong University of Science and Technology
      address:
         name:Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:Huazhong University of Science and Technology
      address:
         name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:Huazhong University of Science and Technology
      address:
         name:Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
      name:Huazhong University of Science and Technology
      address:
         name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Li Liu
      affiliation:
            name:Huazhong University of Science and Technology
            address:
               name:Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Junxia Yao
      affiliation:
            name:Huazhong University of Science and Technology
            address:
               name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Qian Ding
      affiliation:
            name:Huazhong University of Science and Technology
            address:
               name:Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
      name:Shiang Huang
      affiliation:
            name:Huazhong University of Science and Technology
            address:
               name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Huazhong University of Science and Technology, Wuhan, China
      name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
      name:Huazhong University of Science and Technology, Wuhan, China
      name:Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(62)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.04s.